Scarica l'app Stockscreener
3.205
1.38%
-0.045
Precedente Chiudi:
$3.25
Aprire:
$3.22
Volume 24 ore:
17,497
Relative Volume:
0.05
Capitalizzazione di mercato:
$254.34M
Reddito:
$351.37M
Utile/perdita netta:
$-174.01M
Rapporto P/E:
-1.5483
EPS:
-2.07
Flusso di cassa netto:
$-126.94M
1 W Prestazione:
-1.38%
1M Prestazione:
+10.52%
6M Prestazione:
+7.55%
1 anno Prestazione:
-2.58%
Intervallo 1D:
$3.19
$3.24
Intervallo di 1 settimana:
$3.15
$3.335
Portata 52W:
$2.455
$4.02
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Nome
Atea Pharmaceuticals Inc
Settore
Industria
Telefono
857-204-8109
Indirizzo
225 FRANKLIN STREET, BOSTON
Confronta AVIR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.205 | 257.91M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.72 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.12 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-10-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | Iniziato | Evercore ISI | Outperform |
| 2020-11-24 | Iniziato | JP Morgan | Overweight |
| 2020-11-24 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie
Backtesting results for Atea Pharmaceuticals Inc. trading strategiesEarnings Beat & Risk Managed Investment Entry Signals - newser.com
Is a relief rally coming for Atea Pharmaceuticals Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Is Atea Pharmaceuticals Inc. still worth holding after the dipBuy Signal & Consistent Return Investment Signals - newser.com
Atea Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Update & Verified Momentum Watchlists - newser.com
Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - newser.com
Is Atea Pharmaceuticals Inc. stock cheap at current valuation2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Atea Pharmaceuticals, Inc. (AVIR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Atea Pharmaceuticals Advances with Key Phase 1 Study on Bemnifosbuvir/Ruzasvir - MSN
Live market analysis of Atea Pharmaceuticals Inc.2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Atea Pharmaceuticals Inc Stock Analysis and ForecastFlag and Pennant Patterns & Outstanding Portfolio Growth - earlytimes.in
Atea Pharmaceuticals, Inc. (AVIR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Atea Pharmaceuticals (AVIR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Applying sector rotation models to Atea Pharmaceuticals Inc.Weekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Using economic indicators to assess Atea Pharmaceuticals Inc. potentialMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
What drives Atea Pharmaceuticals Inc stock priceDividend Reinvestment Plans & Free Fastest Return On Investment - earlytimes.in
Will Atea Pharmaceuticals Inc. stock split attract more investorsIPO Watch & Daily Profit Maximizing Trade Tips - fcp.pa.gov.br
Will Atea Pharmaceuticals Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Entry Point Alerts - fcp.pa.gov.br
Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer? - TipRanks
Atea Pharmaceuticals’ Promising HCV Treatment Study: Key Insights for Investors - TipRanks
Custom strategy builders for tracking Atea Pharmaceuticals Inc.Dollar Strength & Capital Efficiency Focused Ideas - newser.com
Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atea Pharmaceuticals Inc Azioni (AVIR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):